The List of Selected Biological Medicinal Products

Updated 20 June 2025

The following list of selected biological medicinal products is continuously updated by the Danish Medicines Agency, and all new biological medicinal products are added to the list as they enter the market.

Focus on Reports of Suspected Side Effects

Since the Danish Medicines Agency monitors side effects of all approved and marketed medicines in Denmark, our monitoring of selected biological medicinal products aims to increase the likelihood of detecting any batch-related side effect issues.

All reports of suspected side effects related to medicines on this list should, as far as possible, include information about the medicines product name and batch number. The requirements for the contents of a side effect report are outlined in § 7 of the Executive Order on Reporting of Adverse Reactions to Medicinal Products etc. (No. 1823 of December 15, 2015).

All reports concerning biological medicinal products, including biosimilar products, are quality-assured upon receipt. If a report concerning a medicine on this list lacks the product name and batch number, the Danish Medicines Agency will, where possible, obtain this information.

All medicines on this list also appear on the list of medicines with stricter reporting obligations. This means that doctors, dentists, and midwives are required to report all suspected side effects of the given medicine.

Continuous Evaluation of the List

The Danish Medicines Agency regularly assesses whether medicines should remain on the list. If no safety signals are observed or very few side effect reports are received over time, despite a certain usage level, medicines are removed from the list (though not earlier than two years after the first marketing date).

Older biological medicinal products may also be added to the list if it is deemed necessary to collect more data in order to assess patient safety.

Stay Updated on Revisions

You can stay updated on revisions to the list of selected biological medicinal products. On the homepage of lmst.dk, under News, you can subscribe to the category Notifications about medicines to healthcare professionals”.

List of Selected Biological Medicinal Products

Below is the list of selected biological medicinal products – sorted alphabetically by active substance. The list was last updated 12 July 2024.

Reminder: Healthcare professionals are required to record the medicine product name and batch number when reporting suspected side effects related to medicines on this list.

Product Name

Active Substance

Date of Marketing

Eylea

Aflibercept

19-02-2024

Prolastina Alfa-1 Proteinaseinhibitor, Humant 08-01-2024

Saphnelo

Anifrolumab

18-04-2022

Atgam  Anti T-Lymphocyt Immunoglobulin
14-11-2022

Nexviadyme

Avalglucosidase-alfa

05-09-2022

Bimzelx

Bimekizumab

18-10-2021

Libtayo

Cemiplimab

28-11-2019

Pombiliti Cipaglucosidase Alfa
18-03-2024
Enrylaze
Crisantaspase
11-12-2023
Erwinase Crisantaspase
22-01-2024

Jivi

Damoctocog Alfa Pegol

29-07-2019

BEKEMV
Eculizumab
24-07-2023
Tepkinly
Epcoritamab
13-11-2023
Binocrit
Epoetin Alfa
05-02-2024

VYEPTI

Eptinezumab

05-09-2022

Vabysmo

Faricimab

12-12-2022

Accofil

Filgrastim

10-01-2022

Columvi
Glofitamab
18-09-2023

Novabig

Hepatitis B Immunoglobulin, Human

10-01-2022

Flixabi

Infliximab

28-06-2021

Sarclisa
Isatuximab
10-08-2020
Ebglyss Lebrikizumab
05-02-2024
Lonquex
Lipegfilgrastim
30-10-2023
Omvoh
Mirikizumab
16-10-2023

Opdualag

Nivolumab, Relatlimab

20-03-2023

Spinraza

Nusinersen

03-07-2017

Kesimpta

Ofatumumab

09-08-2021

Pegasys
Peginterferon Alfa-2a
18-03-2024
Elfabrio
Pegunigalsidase Alfa
07-08-2023
Phesgo
Pertuzumab, Trastuzumab
08-03-2021

Polivy

Polatuzumab Vedotin

27-07-2020

Ranivisio
Ranibizumab
21-08-2023
Ultomiris
Ravulizumab
28-12-2020

Skyrizi

Risankizumab

03-06-2019

Trodelvy

Sacituzumab Govitecan

21-02-2022

Sogroya
Somapacitan
24-07-2023
Spevigo
Spesolimab
17-04-2023
Enjaymo
Sutimlimab
12-06-2023
TALVEY
Talquetamab
13-11-2023

KIMMTRAK

Tebentafusp

20-02-2023

TECVAYLI

Teclistamab

14-11-2022

Sondelbay

Teriparatide

31-10-2022

Tetridar

Teriparatide Acetate

13-07-2022

Tezspire Tezepelumab
28-11-2022

Adtralza

Tralokinumab

26-07-2021

IMJUDO
Tremelimumab
01-05-2023

Esperoct

Turoctocog Alfa

04-11-2019